Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Prothrombin Complex Concentrate (PCC) Drug Market Growth 2022-2028

  • LP 4959977
  • 94 Pages
  • June 2022
  • Healthcare
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prothrombin Complex Concentrate (PCC) Drug will have significant change from previous year. According to our (LP Information) latest study, the global Prothrombin Complex Concentrate (PCC) Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prothrombin Complex Concentrate (PCC) Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Prothrombin Complex Concentrate (PCC) Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prothrombin Complex Concentrate (PCC) Drug market, reaching US$ million by the year 2028. As for the Europe Prothrombin Complex Concentrate (PCC) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Prothrombin Complex Concentrate (PCC) Drug players cover Takeda, CSL Behring GmbH, Grifols Biologicals, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prothrombin Complex Concentrate (PCC) Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hemophilia B

Vitamin K Deficiency

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Takeda

CSL Behring GmbH

Grifols Biologicals

Octapharma

Hualan Biological

Meheco Xinxing Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prothrombin Complex Concentrate (PCC) Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prothrombin Complex Concentrate (PCC) Drug by Country/Region, 2017, 2022 & 2028

2.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Type

2.2.1 500 IU/Vial

2.2.2 600 IU/Vial

2.2.3 1000 IU/Vial

2.2.4 Others

2.3 Prothrombin Complex Concentrate (PCC) Drug Sales by Type

2.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Type (2017-2022)

2.4 Prothrombin Complex Concentrate (PCC) Drug Segment by Application

2.4.1 Hemophilia B

2.4.2 Vitamin K Deficiency

2.4.3 Others

2.5 Prothrombin Complex Concentrate (PCC) Drug Sales by Application

2.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Application (2017-2022)

3 Global Prothrombin Complex Concentrate (PCC) Drug by Company

3.1 Global Prothrombin Complex Concentrate (PCC) Drug Breakdown Data by Company

3.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales by Company (2020-2022)

3.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2022)

3.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2022)

3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2022)

3.3 Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Company

3.4 Key Manufacturers Prothrombin Complex Concentrate (PCC) Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prothrombin Complex Concentrate (PCC) Drug Product Location Distribution

3.4.2 Players Prothrombin Complex Concentrate (PCC) Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prothrombin Complex Concentrate (PCC) Drug by Geographic Region

4.1 World Historic Prothrombin Complex Concentrate (PCC) Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue by Geographic Region

4.2 World Historic Prothrombin Complex Concentrate (PCC) Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue by Country/Region

4.3 Americas Prothrombin Complex Concentrate (PCC) Drug Sales Growth

4.4 APAC Prothrombin Complex Concentrate (PCC) Drug Sales Growth

4.5 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Growth

4.6 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Growth

5 Americas

5.1 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Country

5.1.1 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)

5.1.2 Americas Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)

5.2 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Type

5.3 Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Region

6.1.1 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2017-2022)

6.1.2 APAC Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2017-2022)

6.2 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Type

6.3 APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prothrombin Complex Concentrate (PCC) Drug by Country

7.1.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)

7.1.2 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)

7.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Type

7.3 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug by Country

8.1.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Type

8.3 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug

10.3 Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug

10.4 Industry Chain Structure of Prothrombin Complex Concentrate (PCC) Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prothrombin Complex Concentrate (PCC) Drug Distributors

11.3 Prothrombin Complex Concentrate (PCC) Drug Customer

12 World Forecast Review for Prothrombin Complex Concentrate (PCC) Drug by Geographic Region

12.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Forecast by Region

12.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Forecast by Region (2023-2028)

12.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prothrombin Complex Concentrate (PCC) Drug Forecast by Type

12.7 Global Prothrombin Complex Concentrate (PCC) Drug Forecast by Application

13 Key Players Analysis

13.1 Takeda

13.1.1 Takeda Company Information

13.1.2 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Offered

13.1.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Main Business Overview

13.1.5 Takeda Latest Developments

13.2 CSL Behring GmbH

13.2.1 CSL Behring GmbH Company Information

13.2.2 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Offered

13.2.3 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Behring GmbH Main Business Overview

13.2.5 CSL Behring GmbH Latest Developments

13.3 Grifols Biologicals

13.3.1 Grifols Biologicals Company Information

13.3.2 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Offered

13.3.3 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Grifols Biologicals Main Business Overview

13.3.5 Grifols Biologicals Latest Developments

13.4 Octapharma

13.4.1 Octapharma Company Information

13.4.2 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Offered

13.4.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma Main Business Overview

13.4.5 Octapharma Latest Developments

13.5 Hualan Biological

13.5.1 Hualan Biological Company Information

13.5.2 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Offered

13.5.3 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hualan Biological Main Business Overview

13.5.5 Hualan Biological Latest Developments

13.6 Meheco Xinxing Pharma

13.6.1 Meheco Xinxing Pharma Company Information

13.6.2 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Offered

13.6.3 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Meheco Xinxing Pharma Main Business Overview

13.6.5 Meheco Xinxing Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prothrombin Complex Concentrate (PCC) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prothrombin Complex Concentrate (PCC) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 500 IU/Vial

Table 4. Major Players of 600 IU/Vial

Table 5. Major Players of 1000 IU/Vial

Table 6. Major Players of Others

Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)

Table 8. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)

Table 9. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)

Table 13. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)

Table 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022)

Table 15. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Company (2020-2022) & (K Units)

Table 18. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Company (2020-2022)

Table 19. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Prothrombin Complex Concentrate (PCC) Drug Producing Area Distribution and Sales Area

Table 23. Players Prothrombin Complex Concentrate (PCC) Drug Products Offered

Table 24. Prothrombin Complex Concentrate (PCC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)

Table 36. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)

Table 40. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)

Table 42. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2017-2022) & (K Units)

Table 44. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)

Table 48. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)

Table 50. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)

Table 52. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)

Table 56. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)

Table 58. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Prothrombin Complex Concentrate (PCC) Drug

Table 68. Key Market Challenges & Risks of Prothrombin Complex Concentrate (PCC) Drug

Table 69. Key Industry Trends of Prothrombin Complex Concentrate (PCC) Drug

Table 70. Prothrombin Complex Concentrate (PCC) Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Prothrombin Complex Concentrate (PCC) Drug Distributors List

Table 73. Prothrombin Complex Concentrate (PCC) Drug Customer List

Table 74. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Forecast by Region

Table 76. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Prothrombin Complex Concentrate (PCC) Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Takeda Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Takeda Prothrombin Complex Concentrate (PCC) Drug Product Offered

Table 96. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Takeda Main Business

Table 98. Takeda Latest Developments

Table 99. CSL Behring GmbH Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Offered

Table 101. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. CSL Behring GmbH Main Business

Table 103. CSL Behring GmbH Latest Developments

Table 104. Grifols Biologicals Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Offered

Table 106. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Grifols Biologicals Main Business

Table 108. Grifols Biologicals Latest Developments

Table 109. Octapharma Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Offered

Table 111. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Octapharma Main Business

Table 113. Octapharma Latest Developments

Table 114. Hualan Biological Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Offered

Table 116. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Hualan Biological Main Business

Table 118. Hualan Biological Latest Developments

Table 119. Meheco Xinxing Pharma Basic Information, Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Offered

Table 121. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Meheco Xinxing Pharma Main Business

Table 123. Meheco Xinxing Pharma Latest Developments

List of Figures

Figure 1. Picture of Prothrombin Complex Concentrate (PCC) Drug

Figure 2. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 500 IU/Vial

Figure 10. Product Picture of 600 IU/Vial

Figure 11. Product Picture of 1000 IU/Vial

Figure 12. Product Picture of Others

Figure 13. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type in 2021

Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2022)

Figure 15. Prothrombin Complex Concentrate (PCC) Drug Consumed in Hemophilia B

Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Market: Hemophilia B (2017-2022) & (K Units)

Figure 17. Prothrombin Complex Concentrate (PCC) Drug Consumed in Vitamin K Deficiency

Figure 18. Global Prothrombin Complex Concentrate (PCC) Drug Market: Vitamin K Deficiency (2017-2022) & (K Units)

Figure 19. Prothrombin Complex Concentrate (PCC) Drug Consumed in Others

Figure 20. Global Prothrombin Complex Concentrate (PCC) Drug Market: Others (2017-2022) & (K Units)

Figure 21. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application in 2021

Figure 23. Prothrombin Complex Concentrate (PCC) Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Company in 2021

Figure 25. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)

Figure 30. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)

Figure 32. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)

Figure 34. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2021

Figure 38. Americas Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in 2021

Figure 39. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region in 2021

Figure 44. APAC Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Regions in 2021

Figure 45. China Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2021

Figure 52. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in 2021

Figure 53. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Prothrombin Complex Concentrate (PCC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug in 2021

Figure 66. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug

Figure 67. Industry Chain Structure of Prothrombin Complex Concentrate (PCC) Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370